Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""bilirubin"" wg kryterium: Temat


Tytuł:
Age-specific reference intervals for liver function tests in healthy neonates, infants, and young children in Iran.
Autorzy:
Badakhshan SN; Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
Ghazizadeh H; CALIPER Program, Division of Clinical Biochemistry, Pediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.; International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran.
Mohammadi-Bajgiran M; International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran.
Esmaily H; Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.; Department of Biostatistics, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran.
Khorasani MY; International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran.
Bohn MK; CALIPER Program, Division of Clinical Biochemistry, Pediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Pashirzad M; International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran.; Department of Clinical Biochemistry, School of Medicine, Mashhad University of Medical Science, Mashhad, Iran.
Khodabandeh AK; International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran.
Zadeh SG; Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
Alami-Arani I; Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
Rahimi H; International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran.
Ferns GA; Brighton & Sussex Medical School, Division of Medical Education, Falmer, Brighton, UK.
Boskabadi H; Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Assaran-Darban R; Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
Adeli K; CALIPER Program, Division of Clinical Biochemistry, Pediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Ghayour-Mobarhan M; International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran.
Pokaż więcej
Źródło:
Journal of clinical laboratory analysis [J Clin Lab Anal] 2023 Dec; Vol. 37 (23-24), pp. e24995. Date of Electronic Publication: 2023 Dec 12.
Typ publikacji:
Journal Article
MeSH Terms:
Bilirubin*
Infant ; Infant, Newborn ; Humans ; Child ; Child, Preschool ; Liver Function Tests ; Iran ; Reference Values ; Age Factors
Czasopismo naukowe
Tytuł:
Icariin alleviates high-fat diet-induced nonalcoholic fatty liver disease via up-regulating miR-206 to mediate NF-κB and MAPK pathways.
Autorzy:
Zhao H; Department of General Surgery Gastric Ward II, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Tian H; Department of Urology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Pokaż więcej
Źródło:
Journal of biochemical and molecular toxicology [J Biochem Mol Toxicol] 2024 Jan; Vol. 38 (1), pp. e23566. Date of Electronic Publication: 2023 Oct 27.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/drug therapy
Non-alcoholic Fatty Liver Disease*/etiology
MicroRNAs*/genetics
MicroRNAs*/metabolism
Flavonoids*
Rats ; Animals ; NF-kappa B/metabolism ; Cholesterol, LDL/metabolism ; Cholesterol, LDL/pharmacology ; Cholesterol, LDL/therapeutic use ; Diet, High-Fat/adverse effects ; Interleukin-6/metabolism ; Liver/metabolism ; Triglycerides ; Bilirubin/metabolism ; Interleukin-12/metabolism ; Interleukin-12/pharmacology ; Interleukin-12/therapeutic use
Czasopismo naukowe
Tytuł:
Reply to 'The 50 shades of bilirubin'. Letter regarding the article 'Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF'.
Autorzy:
Adamson C; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Nov; Vol. 24 (11), pp. 2206-2207. Date of Electronic Publication: 2022 Sep 20.
Typ publikacji:
Letter; Comment
MeSH Terms:
Bilirubin*
Heart Failure*/diagnosis
Humans ; Liver
Opinia redakcyjna
Tytuł:
The 50 shades of bilirubin. Letter regarding the article 'Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF'.
Autorzy:
Krawczyk M; Department of Medicine II, Saarland University Medical Centre, Saarland University, Homburg, Germany.; Laboratory of Metabolic Liver Diseases, Department of General, Transplant and Liver Surgery, Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
Böhm M; Department of Internal Medicine III, Cardiology, Angiology and Intensive Care Medicine, Saarland University, Homburg, Germany.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Nov; Vol. 24 (11), pp. 2206. Date of Electronic Publication: 2022 Sep 16.
Typ publikacji:
Letter; Comment
MeSH Terms:
Bilirubin*
Heart Failure*/diagnosis
Humans ; Liver
Opinia redakcyjna
Tytuł:
Acute fatty liver of pregnancy causing multiple organ dysfunction syndrome in a Chinese intensive care unit.
Autorzy:
Shen Y; Department of Nursing, Shanghai General Hospital, Shanghai, China.
Wang X; Department of Nursing, Shanghai General Hospital, Shanghai, China.
Yao Y; Department of Nursing, Shanghai General Hospital, Shanghai, China.
Zhou X; Department of Nursing, Shanghai General Hospital, Shanghai, China.
Pokaż więcej
Źródło:
Nursing in critical care [Nurs Crit Care] 2023 Nov; Vol. 28 (6), pp. 1170-1175. Date of Electronic Publication: 2023 Apr 28.
Typ publikacji:
Case Reports
MeSH Terms:
Multiple Organ Failure*/etiology
Multiple Organ Failure*/therapy
Cesarean Section*
Humans ; Female ; Pregnancy ; Intensive Care Units ; Bilirubin
SCR Disease Name:
Acute fatty liver of pregnancy
Raport
Tytuł:
Bile duct ligation increased dopamine levels in the cerebral cortex of rats partly due to induction of tyrosine hydroxylase.
Autorzy:
Kong W; Center of Drug Metabolism and Pharmacokinetics, School of Pharmacy, China Pharmaceutical University, Nanjing, China.; School of Pharmacy, Bengbu Medical College, 2600 Donghai Road, Bengbu, Anhui, China.
Sun X; Center of Drug Metabolism and Pharmacokinetics, School of Pharmacy, China Pharmaceutical University, Nanjing, China.
Yu S; Center of Drug Metabolism and Pharmacokinetics, School of Pharmacy, China Pharmaceutical University, Nanjing, China.
Liu P; Center of Drug Metabolism and Pharmacokinetics, School of Pharmacy, China Pharmaceutical University, Nanjing, China.
Zheng X; Center of Drug Metabolism and Pharmacokinetics, School of Pharmacy, China Pharmaceutical University, Nanjing, China.
Zhang J; Hunan Provincial People's Hospital (The first-affiliated hospital of Hunan Normal University), Changsha, China.
Zhu L; Center of Drug Metabolism and Pharmacokinetics, School of Pharmacy, China Pharmaceutical University, Nanjing, China.
Jiang T; Center of Drug Metabolism and Pharmacokinetics, School of Pharmacy, China Pharmaceutical University, Nanjing, China.
Jin M; Center of Drug Metabolism and Pharmacokinetics, School of Pharmacy, China Pharmaceutical University, Nanjing, China.
Gao J; Center of Drug Metabolism and Pharmacokinetics, School of Pharmacy, China Pharmaceutical University, Nanjing, China.
Fan X; Center of Drug Metabolism and Pharmacokinetics, School of Pharmacy, China Pharmaceutical University, Nanjing, China.
Liu X; Center of Drug Metabolism and Pharmacokinetics, School of Pharmacy, China Pharmaceutical University, Nanjing, China.
Liu L; Center of Drug Metabolism and Pharmacokinetics, School of Pharmacy, China Pharmaceutical University, Nanjing, China.
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2023 Jul; Vol. 180 (13), pp. 1690-1709. Date of Electronic Publication: 2023 Feb 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neuroblastoma*/metabolism
Liver Failure*/metabolism
Rats ; Humans ; Animals ; Tyrosine 3-Monooxygenase/metabolism ; Dopamine/metabolism ; NF-kappa B/metabolism ; Bile Ducts/surgery ; Hyperbilirubinemia/metabolism ; Bilirubin/metabolism ; Bilirubin/pharmacology ; Ligation ; Cerebral Cortex/metabolism ; Liver/metabolism
Czasopismo naukowe
Tytuł:
Molecular mechanisms of oxidative stress-related neonatal jaundice.
Autorzy:
Perrone S; Department of Medicine and Surgery, Neonatology Unit, 'Azienda Ospedaliero Universitaria di Parma, University of Parma, Parma, Italy.
Lembo C; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Giordano M; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Petrolini C; Department of Medicine and Surgery, Neonatology Unit, 'Azienda Ospedaliero Universitaria di Parma, University of Parma, Parma, Italy.
Cannavò L; Department of Human Pathology in Adult and Developmental Age 'Gaetano Barresi', University of Messina, Messina, Italy.
Gitto E; Department of Human Pathology in Adult and Developmental Age 'Gaetano Barresi', University of Messina, Messina, Italy.
Pokaż więcej
Źródło:
Journal of biochemical and molecular toxicology [J Biochem Mol Toxicol] 2023 Jun; Vol. 37 (6), pp. e23349. Date of Electronic Publication: 2023 Apr 03.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Jaundice, Neonatal*/pathology
Infant, Newborn ; Humans ; Antioxidants/pharmacology ; Oxidative Stress/physiology ; Hyperbilirubinemia/pathology ; Bilirubin ; Erythrocytes ; Free Radicals/pharmacology ; Oxidants/pharmacology
Czasopismo naukowe
Tytuł:
Cerebrospinal fluid biomarkers of superficial siderosis in patients with spontaneous intracranial hypotension.
Autorzy:
Häni L; Department of Neurosurgery, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.; Department of Neurosurgery, Medical Center - University of Freiburg, Freiburg, Germany.
Fung C; Department of Neurosurgery, Medical Center - University of Freiburg, Freiburg, Germany.
Jesse CM; Department of Neurosurgery, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
Schild C; University Institute of Clinical Chemistry, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
Piechowiak EI; Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
Dobrocky T; Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
Raabe A; Department of Neurosurgery, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
Beck J; Department of Neurosurgery, Medical Center - University of Freiburg, Freiburg, Germany.
Pokaż więcej
Źródło:
European journal of neurology [Eur J Neurol] 2023 Jan; Vol. 30 (1), pp. 235-240. Date of Electronic Publication: 2022 Oct 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Intracranial Hypotension*/complications
Intracranial Hypotension*/diagnostic imaging
Intracranial Hypotension*/cerebrospinal fluid
Siderosis*/complications
Siderosis*/diagnostic imaging
Humans ; Magnetic Resonance Imaging/methods ; Biomarkers ; Ferritins ; Bilirubin
Czasopismo naukowe
Tytuł:
Metabolic profiling of emodin drug-induced liver injury and silybin treatment in rats using ultra-performance liquid chromatography-quadrupole-time-of-flight-mass spectrometry: A metabolomic and mechanistic approach.
Autorzy:
Chen C; Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, P. R. China.
Qian J; Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, P. R. China.
Zhao X; Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, P. R. China.
Han X; Beijing Institute of Traditional Chinese Medicine, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, P. R. China.
Tang X; Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, P. R. China.
Gao J; Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, P. R. China.
Liu Y; Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, P. R. China.
Jiang J; Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, P. R. China.
Wen B; Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, P. R. China.
Pokaż więcej
Źródło:
Biomedical chromatography : BMC [Biomed Chromatogr] 2022 Nov; Vol. 36 (11), pp. e5469. Date of Electronic Publication: 2022 Aug 12.
Typ publikacji:
Journal Article
MeSH Terms:
Chemical and Drug Induced Liver Injury*/metabolism
Emodin*/metabolism
Fatty Liver*/metabolism
Fatty Liver*/pathology
ATP Binding Cassette Transporter, Subfamily B, Member 11 ; Animals ; Aspartate Aminotransferases ; Bile Acids and Salts/metabolism ; Bilirubin/metabolism ; Bilirubin/pharmacology ; Biomarkers/metabolism ; Cholesterol ; Chromatography, Liquid ; Glycerophospholipids/metabolism ; Liver/metabolism ; Mass Spectrometry ; RNA, Messenger/metabolism ; RNA, Messenger/pharmacology ; Rats ; Silybin/metabolism ; Silybin/pharmacology ; Vitamins/metabolism ; Vitamins/pharmacology
Czasopismo naukowe
Tytuł:
Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF.
Autorzy:
Adamson C; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Cowan LM; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
de Boer RA; Department of Cardiology, University Medical Center and University of Groningen, Groningen, The Netherlands.
Diez M; Division of Cardiology, Institute Cardiovascular de Buenos Aires, Buenos Aires, Argentina.
Drożdż J; Department Cardiology, Medical University of Lodz, Lodz, Poland.
Dukát A; Fifth Department of Internal Medicine, Comenius University in Bratislava, Bratislava, Slovakia.
Inzucchi SE; Section of Endocrinology, Yale School of Medicine, New Haven, CT, USA.
Køber L; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City, MO, USA.; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
Ljungman CEA; Institute of Medicine, Department of Molecular and Clinical Medicine/Cardiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Martinez FA; Universidad Nacional de Córdoba, Córdoba, Argentina.
Ponikowski P; Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland.
Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Lindholm D; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Bengtsson O; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Boulton DW; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gaithersburg, MD, USA.
Greasley PJ; Early Research and Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Langkilde AM; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Sjöstrand M; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Oct; Vol. 24 (10), pp. 1856-1868. Date of Electronic Publication: 2022 Aug 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure*
Humans ; Stroke Volume ; Ventricular Function, Left ; Bilirubin ; Liver
Czasopismo naukowe
Tytuł:
Population Pharmacokinetic Modeling of Lenvatinib in Chinese Patients With Advanced Hepatocellular Carcinoma Using Real-World Data.
Autorzy:
Hu Y; Department of Pharmacy, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.
Chen R; Department of Pharmacy, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.
Ye Z; Clinical Research Center for Phase I, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.
Wei F; Department of Hepatopancreatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.
Lin K; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Liu J; Fujian Medical University Cancer Hospital and Fujian Cancer Hospital, Fuzhou, China.
Zeng Y; Department of Hepatopancreatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.
Pokaż więcej
Źródło:
Journal of clinical pharmacology [J Clin Pharmacol] 2022 Dec; Vol. 62 (12), pp. 1507-1517. Date of Electronic Publication: 2022 Sep 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Liver Neoplasms*/drug therapy
Quinolines*/therapeutic use
Humans ; Female ; Male ; Alkaline Phosphatase ; Phenylurea Compounds/therapeutic use ; Bilirubin
Czasopismo naukowe
Tytuł:
Effects of dietary inclusion of Bambara groundnut and sweet orange peels on streptozotocin/HFD type-2 induced diabetes mellitus complications and related biochemical parameters.
Autorzy:
Oguntuase SO; Department of Chemistry, Federal University of Technology, Akure, Nigeria.
Fasakin OW; Department of Biochemistry, Federal University of Technology, Akure, Nigeria.
Oyeleye SI; Department of Biochemistry, Federal University of Technology, Akure, Nigeria.
Oboh G; Department of Biochemistry, Federal University of Technology, Akure, Nigeria.
Pokaż więcej
Źródło:
Journal of food biochemistry [J Food Biochem] 2022 Nov; Vol. 46 (11), pp. e14373. Date of Electronic Publication: 2022 Aug 07.
Typ publikacji:
Journal Article
MeSH Terms:
Citrus sinensis*
Vigna*
Diabetes Complications*
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/etiology
Male ; Rats ; Animals ; Streptozocin/adverse effects ; Diet, High-Fat ; Reactive Oxygen Species ; Uric Acid ; Creatinine ; Bilirubin ; Albumins
Czasopismo naukowe
Tytuł:
Alterations in gut microbiota and elevated serum bilirubin in primary biliary cholangitis patients treated with ursodeoxycholic acid.
Autorzy:
Han W; Department of Liver Disease Center, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Huang C; Second Department of liver disease center, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Zhang Q; Department of Liver Disease Center, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Tao S; Department of Liver Disease Center, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Hu X; Department of Liver Disease Center, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Xu J; Department of Liver Disease Center, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Jiang R; Department of Liver Disease Center, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Xu B; Second Department of liver disease center, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Liu Y; Second Department of liver disease center, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Hou J; Department of Liver Disease Center, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Pokaż więcej
Źródło:
European journal of clinical investigation [Eur J Clin Invest] 2022 Feb; Vol. 52 (2), pp. e13714. Date of Electronic Publication: 2021 Dec 09.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Gastrointestinal Microbiome*
Bilirubin/*blood
Cholagogues and Choleretics/*therapeutic use
Liver Cirrhosis, Biliary/*blood
Liver Cirrhosis, Biliary/*drug therapy
Liver Cirrhosis, Biliary/*microbiology
Ursodeoxycholic Acid/*therapeutic use
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies
Czasopismo naukowe
Tytuł:
Interference of eltrombopag with bilirubin measurements on the Vitros 5600 analyzer.
Autorzy:
Poventud-Fuentes I; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.; Section of Clinical Chemistry, Division of Laboratory Medicine, Department of Pathology, Texas Children's Hospital, Houston, TX, USA.
Garnett E; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.; Section of Clinical Chemistry, Division of Laboratory Medicine, Department of Pathology, Texas Children's Hospital, Houston, TX, USA.
Despotovic J; Cancer Center, Texas Children's Hospital, Houston, TX, USA.
Devaraj S; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.; Section of Clinical Chemistry, Division of Laboratory Medicine, Department of Pathology, Texas Children's Hospital, Houston, TX, USA.
Pokaż więcej
Źródło:
Journal of clinical laboratory analysis [J Clin Lab Anal] 2021 Aug; Vol. 35 (8), pp. e23796. Date of Electronic Publication: 2021 Jun 19.
Typ publikacji:
Journal Article
MeSH Terms:
Benzoates/*blood
Bilirubin/*blood
Blood Chemical Analysis/*methods
Hydrazines/*blood
Pyrazoles/*blood
Artifacts ; Blood Chemical Analysis/instrumentation ; Humans ; Reference Values
Czasopismo naukowe
Tytuł:
Effect of Silymarin Treatment on Circulating Bilirubin and Cardiovascular Disease Risk Factors in Healthy Men: A Single-Blind, Randomized Crossover Trial.
Autorzy:
Vidimce J; School of Pharmacy and Medical Science, Griffith University, Gold Coast, Queensland, Australia.
Pennell EN; School of Pharmacy and Medical Science, Griffith University, Gold Coast, Queensland, Australia.
Foo M; School of Pharmacy and Medical Science, Griffith University, Gold Coast, Queensland, Australia.
Shiels RG; School of Pharmacy and Medical Science, Griffith University, Gold Coast, Queensland, Australia.
Shibeeb S; School of Pharmacy and Medical Science, Griffith University, Gold Coast, Queensland, Australia.; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
Watson M; Institute of Health & Biomedical Innovation, Translational Research Institute, Queensland University of Technology, Brisbane, Queensland, Australia.
Bulmer AC; School of Pharmacy and Medical Science, Griffith University, Gold Coast, Queensland, Australia.
Pokaż więcej
Źródło:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2021 Oct; Vol. 10 (10), pp. 1156-1165. Date of Electronic Publication: 2021 Jul 09.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Antioxidants/*therapeutic use
Bilirubin/*blood
Cardiovascular Diseases/*blood
Cardiovascular Diseases/*drug therapy
Silymarin/*therapeutic use
Adult ; Biomarkers/blood ; Cardiovascular Diseases/epidemiology ; Cross-Over Studies ; Humans ; Male ; Queensland/epidemiology ; Risk Factors ; Single-Blind Method ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł:
Diagnostic and predictive ability of hyperbilirubinemia severity in cats: A multicenter retrospective study
Autorzy:
Xavier Salord Torres
Kamalan Jeevaratnam
Imogen Schofield
Samantha Taylor
Jennifer Stallwood
Menai Heyes
Daniel Hughes
Pieter Defauw
Pokaż więcej
Temat:
biliary
bilirubin
icterus
jaundice
liver
obstruction
Veterinary medicine
SF600-1100
Źródło:
Journal of Veterinary Internal Medicine, Vol 38, Iss 2, Pp 1043-1050 (2024)
Opis pliku:
electronic resource
Relacje:
https://doaj.org/toc/0891-6640; https://doaj.org/toc/1939-1676
Dostęp URL:
https://doaj.org/article/f76867e45a514713a2e2b4dae82062f3  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Association between bilirubin and chronic kidney disease in hypertensive patients: The China hypertension registry study
Autorzy:
Peixu Zhao
Haitao Xu
Yumeng Shi
Xiaoli Song
Guosheng Qiu
Congcong Ding
Wei Zhou
Chao Yu
Tao Wang
Lingjuan Zhu
Huihui Bao
Xiaoshu Cheng
Pokaż więcej
Temat:
chronic kidney disease
direct bilirubin
hypertension
indirect bilirubin
Diseases of the circulatory (Cardiovascular) system
RC666-701
Źródło:
The Journal of Clinical Hypertension, Vol 25, Iss 12, Pp 1185-1192 (2023)
Opis pliku:
electronic resource
Relacje:
https://doaj.org/toc/1524-6175; https://doaj.org/toc/1751-7176
Dostęp URL:
https://doaj.org/article/ab989716ac664ab1b49fe89881172e15  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Insulin-like growth factor-1 positively associated with bone formation markers and creatine kinase in adults with general physical activity.
Autorzy:
Lee SC; Department of Laboratory Medicine, Faculty of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Hsiao JK; Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Yang YC; Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Haung JC; Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Tien LY; Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Li DE; Department of Nuclear Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Tsai SM; Department of Public Health and Environmental Medicine, Faculty of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Pokaż więcej
Źródło:
Journal of clinical laboratory analysis [J Clin Lab Anal] 2021 Aug; Vol. 35 (8), pp. e23799. Date of Electronic Publication: 2021 Jun 18.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers/*blood
Creatine Kinase/*blood
Exercise/*physiology
Insulin-Like Growth Factor I/*analysis
Osteogenesis/*physiology
Adult ; Aged ; Alkaline Phosphatase/blood ; Bilirubin/blood ; Female ; Humans ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł:
Primary nonfunction following liver transplantation: Learning of graft metabolites and building a predictive model.
Autorzy:
Zhang X; Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Zhang C; Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Huang H; Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Chen R; Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Lin Y; Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Chen L; Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, China.
Shao L; Health Management Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Liu J; Department of Pathology and Molecular Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Canada.
Ling Q; Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2021 Jul; Vol. 11 (7), pp. e483.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Liver Transplantation*
Graft Survival/*physiology
Bilirubin/analysis ; Humans ; Liver/physiology ; Logistic Models ; Risk Factors ; Time Factors ; Tissue Donors
Raport
Tytuł:
Drug- and Drug Abuse-Associated Hyperbilirubinemia: Experience With Atazanavir.
Autorzy:
Roy-Chowdhury J; Marion Bessin Liver Research Center, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.; Division of Gastroenterology and Liver Diseases, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.; Department of Genetics, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.
Roy-Chowdhury N; Marion Bessin Liver Research Center, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.; Division of Gastroenterology and Liver Diseases, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.; Department of Genetics, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.
Listowsky I; Marion Bessin Liver Research Center, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.; Department of Biochemistry, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.
Wolkoff AW; Marion Bessin Liver Research Center, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.; Division of Gastroenterology and Liver Diseases, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.; Department of Anatomy and Structural Biology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.
Pokaż więcej
Źródło:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2017 Mar; Vol. 6 (2), pp. 140-146.
Typ publikacji:
Journal Article
MeSH Terms:
Atazanavir Sulfate/*adverse effects
Bilirubin/*blood
HIV Protease Inhibitors/*adverse effects
Hyperbilirubinemia/*chemically induced
Animals ; Atazanavir Sulfate/administration & dosage ; Bilirubin/metabolism ; Cells, Cultured ; Female ; Glucuronosyltransferase/antagonists & inhibitors ; Glutathione Transferase/metabolism ; HIV Protease Inhibitors/administration & dosage ; Hepatocytes/metabolism ; Humans ; Hyperbilirubinemia/blood ; Male ; Rats, Wistar ; Ritonavir/administration & dosage ; Substance-Related Disorders/complications
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies